Clinical trial
A Study of Flovent in Patients With Eosinophilic Esophagitis
NCT00426283 · Marc Rothenberg, MD, Other · Completed
Key facts
| NCT number | NCT00426283 |
|---|---|
| Title | A Study of Flovent in Patients With Eosinophilic Esophagitis |
| Official title | A Double Blinded, Randomized Trial of Swallowed 1760mcg Fluticasone Propionate Versus Placebo in the Treatment of Eosinophilic Esophagitis |
| Lead sponsor | Marc Rothenberg, MD, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Eosinophilic Esophagitis |
| Intervention type | Drug, Other |
| Interventions | Flovent, Placebo |
| Enrollment | 42 |
| Start date | Jan 1, 2007 |
| Primary completion | Dec 1, 2011 |
| Completion | Mar 1, 2012 |
| First posted | Jan 24, 2007 |
| Last update posted | Oct 19, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: